Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

University of Texas, Axxam patent CX3CR1 and/or CX3CL1 agonists

Feb. 18, 2021

AstraZeneca discovers arginase-1 and arginase-2 inhibitors

Feb. 18, 2021

Nektar announces new collaborations for registrational study of bempegaldesleukin in SCCHN

Feb. 18, 2021

New HSP90-CDC37 protein-protein interaction inhibitors with antitumor in vitro and in vivo efficacy

Feb. 18, 2021

AstraZeneca discovers PARP-1 inhibitors

Feb. 17, 2021

Lenvatinib plus pembrolizumab improves survival in patients with advanced RCC

Feb. 17, 2021

Sun Pharma Advanced Research describes new SERDs

Feb. 17, 2021

Cell-penetrating peptides developed to target STAT3 for antitumor effects

Feb. 17, 2021

TLX-591-CDx for prostate cancer imaging receives first E.U. approval in Czech Republic

Feb. 16, 2021

BeiGene patents MAP4K1 inhibitors

Feb. 16, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Korsana boosts Alzheimer’s work with reverse merger, $380M financing
BioWorld Science
Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...